Published in Int J Nanomedicine on June 12, 2015
Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals. Drug Des Devel Ther (2017) 0.75
Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov (2008) 12.72
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials (2010) 3.54
Theory of self-assembly of lipid bilayers and vesicles. Biochim Biophys Acta (1977) 3.49
M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J Infect Dis (1986) 3.32
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun (1991) 3.25
The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials (2011) 2.45
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Biomaterials (2009) 2.04
Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment. Bioconjug Chem (2010) 1.98
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol (2010) 1.69
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc (2013) 1.44
A novel size-tunable nanocarrier system for targeted anticancer drug delivery. J Control Release (2010) 1.42
Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir (2006) 1.37
Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm (2009) 1.16
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm (2000) 1.15
Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials (2013) 1.12
Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm (2009) 1.12
Bile acids: from digestion to cancers. Biochimie (2012) 1.08
Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur J Pharm Biopharm (2000) 1.06
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Eur J Pharm Biopharm (2012) 1.05
Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int J Nanomedicine (2011) 1.02
Bile acids and colon cancer: Solving the puzzle with nuclear receptors. Trends Mol Med (2011) 1.01
Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int J Nanomedicine (2011) 1.00
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomedicine (2011) 0.99
Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin (2010) 0.97
Bile acid alkylamide derivatives as low molecular weight organogelators: systematic gelation studies and qualitative structural analysis of the systems. J Colloid Interface Sci (2011) 0.95
Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Release (2005) 0.94
Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment. Nanoscale Res Lett (2013) 0.94
Influence of nanoparticle shape, size, and surface functionalization on cellular uptake. J Nanosci Nanotechnol (2013) 0.93
The role of bile salts in digestion. Adv Colloid Interface Sci (2010) 0.91
Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine (2001) 0.91
Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. J Nanosci Nanotechnol (2006) 0.89
Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomedicine (2012) 0.88
The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv (2014) 0.88
Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt. Eur J Pharm Biopharm (2008) 0.87
Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci (2008) 0.87
Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine (2013) 0.86
Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm (2009) 0.85
M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm (2009) 0.84
Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice. Toxicol Appl Pharmacol (2013) 0.83
Improved stability of highly fluorinated phospholipid-based vesicles in the presence of bile salts. J Control Release (1999) 0.83
Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Int J Pharm (2013) 0.83
Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation. Int J Nanomedicine (2013) 0.82
Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation. Pharm Res (2015) 0.82
Bile salts and their importance for drug absorption. Int J Pharm (2013) 0.82
Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids. Int J Pharm (2010) 0.81
Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study. Int J Pharm (2013) 0.81
Solubilization of resveratrol in micellar solutions of different bile acids. Colloids Surf B Biointerfaces (2009) 0.81
Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes. Br J Pharmacol (2011) 0.81
Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. Eur J Pharm Sci (2000) 0.81
Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media. Int J Pharm (2012) 0.81
Lecithin in mixed micelles attenuates the cytotoxicity of bile salts in Caco-2 cells. Toxicol In Vitro (2012) 0.81
Influence of absorption enhancers (bile salts) and the preservative (benzalkonium chloride) on mucociliary function and permeation barrier function in rabbit tracheas. Eur J Pharm Sci (1998) 0.80
Development of lidocaine gels for enhanced local anesthetic action. Int J Pharm (2004) 0.80
Bilosomes: the answer to oral vaccine delivery? Drug Discov Today (2001) 0.80
Imaging of the GI tract by QDs loaded heparin-deoxycholic acid (DOCA) nanoparticles. Carbohydr Polym (2012) 0.80
Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm (2004) 0.79
The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs. Drug Metab Pharmacokinet (2005) 0.79
Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles. J Control Release (2012) 0.79
Lecithin-based nanostructured gels for skin delivery: an update on state of art and recent applications. J Control Release (2014) 0.79
Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components. Eur J Pharm Biopharm (2011) 0.79
Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res (2006) 0.79
Optimization of systemic nasal drug delivery with pharmaceutical excipients. Adv Drug Deliv Rev (1998) 0.78
Mixed micelle formation with phosphatidylcholines: the influence of surfactants with different molecule structures. Int J Pharm (2009) 0.78
Ion pairing with bile salts modulates intestinal permeability and contributes to food-drug interaction of BCS class III compound trospium chloride. Mol Pharm (2013) 0.78
Study on interaction of bile salts with curcumin and curcumin embedded in dipalmitoyl-sn-glycero-3-phosphocholine liposome. Colloids Surf B Biointerfaces (2013) 0.77
Interactions of phenothiazine drugs with bile salts: micellization and binding studies. J Colloid Interface Sci (2012) 0.77
Effects of bile salts on propranolol distribution into liposomes studied by capillary electrophoresis. J Pharm Biomed Anal (2011) 0.77
Nanoberries for topical delivery of antioxidants. J Cosmet Sci (2014) 0.77
Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies. Int J Pharm (2010) 0.77
The influence of bile acids on the oral bioavailability of vitamin K encapsulated in polymeric micelles. J Control Release (2008) 0.77
Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers. J Control Release (2014) 0.77
Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Drug Deliv (2014) 0.77
Bile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in rats. Int J Pharm (2013) 0.77
Enhanced absorption of oral furosemide by bile juice in rats. Res Commun Mol Pathol Pharmacol (1999) 0.76
A photophysical study on the role of bile salt hydrophobicity in solubilizing amphotericin B aggregates. J Pharm Sci (2009) 0.76
Preparation of cefquinome sulfate proliposome and its pharmacokinetics in rabbit. Iran J Pharm Res (2013) 0.76
Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration. Nanomedicine (2013) 0.76
Enhanced permeability across Caco-2 cell monolayers by specific mannosylating ligand of buserelin acetate proliposomes. J Liposome Res (2015) 0.76
Oral mucosal immunization using glucomannosylated bilosomes. J Biomed Nanotechnol (2014) 0.76
Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. J Liposome Res (2013) 0.76
Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. PLoS One (2013) 0.76
Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge. Drug Dev Ind Pharm (2012) 0.76
Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats. Biol Pharm Bull (1999) 0.76
Cholesterol-bile salt vesicles as potential delivery vehicles for drug and vaccine delivery. Int J Pharm (2005) 0.76
Development of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administration. Nanomedicine (Lond) (2015) 0.76
Effect of bile acids on absorption of nitrendipine in healthy subjects. Br J Clin Pharmacol (2001) 0.76
Physicochemical characterization of amphiphilic nanoparticles based on the novel starch-deoxycholic acid conjugates and self-aggregates. Carbohydr Polym (2013) 0.75
Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity. J Pharm Sci (2015) 0.81
Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies. Int J Nanomedicine (2015) 0.79